Forbes Medi-Tech Inc. (Forbes), the maker of Reducol™, is a Bio-pharmaceutical company dedicated to the research, development and commercialisation of innovative prescription pharmaceutical and nutraceutical products for the prevention and treatment of cardiovascular diseases.

Forbes' scientific platform is based on core sterol technology. By extracting plant sterols from coniferous trees, Forbes has developed cholesterol-lowering agents to be used as functional food ingredients and dietary supplements. The Company is continuing to grow its business through a commitment to therapeutic innovation, ongoing research and development and licensing of new technologies.

Forbes Medi-Tech Inc. is a public company, listed on the TSX (Symbol: FMI) and NASDAQ (Symbol: FMTI).

In the last 10 years, Forbes has developed and refined a proprietary process technology to extract phytosterols from tall-oil pitch into their pure, natural crystalline powdered form of a quality acceptable for use in functional foods, nutraceuticals and as starting material for pharmaceutical synthesis.

The Company has an active research and development program, designed to expand Forbes' diversified line of healthcare products targeted to global markets of cholesterol-lowering Nutraceuticals, Functional Foods and dietary supplements. Our primary research is conducted out of selected universities and contract research organisations.

Forbes' research activities also focus on the development of novel prescription medications for cholesterol-lowering and cardiovascular health benefits. These include pharmaceuticals such as FM-VP4 and FM-VPx.

Forbes Medi-Tech Inc. is committed to creating a product pipeline of functional food and nutraceutical ingredients for commercialisation, and extends the opportunity to other companies seeking the formation of strategic partnerships that would derive mutual benefit from Forbes' core phytosterol technology.

From a broad spectrum of the Functional Food and Nutraceutical Industry, Forbes Medi-Tech has assembled a first-class team of internationally recognised experts to direct the Company's focus through new and existing opportunities of commercialisation and medical research innovation. Learn more about our Functional Food Advisory Board.